 |
Monitor Continuous Biocatalytic Reactions Without the Burden of Manual Sampling
Continuous biocatalytic processes offer significant advantages for pharmaceutical manufacturing, including improved selectivity, higher throughput, and more efficient synthetic routes. However, assessing catalyst performance over extended operating periods remains a critical challenge.
Discover how GlaxoSmithKline (GSK) leveraged EasySampler™ technology to automate sampling and monitor continuous transamination reactions for more than 120 hours, enabling accurate enzyme lifetime evaluation and faster process development.
Download the Application Note
Learn how automated, unattended sampling can:
- Eliminate labor-intensive manual sampling procedures
- Generate consistent reaction data over days and weeks
- Enable overnight and weekend monitoring
- Improve process understanding through higher sampling density
- Support accurate enzyme stability and half-life determination
- Increase laboratory productivity and process development efficiency
